Effects of Aliskiren, Ramipril, and the Combination on Levels of Angiotensin II in Patients With Decompensated Systolic Heart Failure

NCT00923156 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

123

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure

Interventions

DRUG: aliskiren
DRUG: ramipril
DRUG: Placebo to aliskiren
DRUG: Placebo to ramipril

Sponsor

Novartis Pharmaceuticals